119th Congress · introduced in the House · Sep 10, 2025
HOPE Act
Official title from Congress.gov
Latest action (Sep 10, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
44 citations; showing the 25 most recently posted.
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Budget/Appropriations
$60,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Disaster Planning/Emergencies
$60,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$60,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Homeland Security
$60,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Homeland Security
$450,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Disaster Planning/Emergencies
$450,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Budget/Appropriations
$450,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Health Issues
$450,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Disaster Planning/Emergencies
$70,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Health Issues
$70,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Homeland Security
$70,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Budget/Appropriations
$70,000
Paid to lobbying firm
…Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Budget/Appropriations
$510,000
Spent on own lobbying
…id Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Health Issues
$510,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Homeland Security
$510,000
Spent on own lobbying
…esponse Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Disaster Planning/Emergencies
$510,000
Spent on own lobbying
…id Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Health Issues
$70,000
Paid to lobbying firm
…for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Budget/Appropriations
$70,000
Paid to lobbying firm
…for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Disaster Planning/Emergencies
$70,000
Paid to lobbying firm
…for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Homeland Security
$70,000
Paid to lobbying firm
…for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 14, 2026 · issue area: Homeland Security
$730,000
Spent on own lobbying
…27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 14, 2026 · issue area: Disaster Planning/Emergencies
$730,000
Spent on own lobbying
…27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 14, 2026 · issue area: Budget/Appropriations
$730,000
Spent on own lobbying
…27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC · lobbying firm or registrant: EMERGENT BIOSOLUTIONS INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 14, 2026 · issue area: Health Issues
$730,000
Spent on own lobbying
…27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMERGENT BIOSOLUTIONS INC. · lobbying firm or registrant: CGCN GROUP, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…aloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing